Compare BANR & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BANR | LMAT |
|---|---|---|
| Founded | 1890 | 1983 |
| Country | United States | United States |
| Employees | N/A | 655 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 2015 | 2006 |
| Metric | BANR | LMAT |
|---|---|---|
| Price | $63.14 | $111.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $69.80 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 219.9K | 194.6K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.16% | 0.87% |
| EPS Growth | 15.57 | ★ 30.57 |
| EPS | ★ 5.64 | 2.52 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | $0.73 | $14.21 |
| Revenue Next Year | $5.69 | $8.88 |
| P/E Ratio | ★ $11.23 | $45.61 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $57.05 | $78.01 |
| 52 Week High | $69.83 | $118.01 |
| Indicator | BANR | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 59.62 | 56.03 |
| Support Level | $60.99 | $81.60 |
| Resistance Level | $64.96 | $113.40 |
| Average True Range (ATR) | 1.08 | 3.19 |
| MACD | 0.27 | -0.06 |
| Stochastic Oscillator | 68.94 | 57.71 |
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho, and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.